Latest Updates

Government initiatives to cut health expenditure are likely to encourage sales of generic medications in Europe, according to a…

MSCDA to meet authorities after July 25 for further discussions

Likely to address patient needs and balance industry growth

Will be available for use globally in all major pharmaceutical and biotechnology markets, including Asia

This nanotechnology-based vial is used to for treating breast, non-small cell lung, prostate, gastric adenocarcinoma, head and…

Will work together to combine their upcyte and Alvetex Scaffold technologies

In 2011, polio cases in Pakistan reached a decade high

Population Genetics to retain commercialisation rights to any biomarkers discovered; results of study expected during this year

Postponement due to a request from lawyers representing Novartis

At the time of the withdrawal the application was under review by the Agency’s Committee for Medicinal Products for Human Use